Aclaris Therapeutics
Aclaris Therapeutics, Inc.
101 Lindenwood Drive
Suite 400
Malvern, PA 19355
Phone: (484) 324-7933Website: https://www.aclaristx.com/Careers: www.aclaristx.com/careers
Latest news
- Aclaris Therapeutics Receives FDA Approval for Eskata (hydrogen peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses
17 December 2017 - FDA Accepts Aclaris Therapeutics’ New Drug Application for Topical Treatment of Seborrheic Keratosis, a Common Skin Condition
9 May 2017 - Aclaris Therapeutics Submits New Drug Application for A-101 as a Novel Treatment for Seborrheic Keratosis – a Common Skin Condition
27 February 2017
Drugs Associated with Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. manufactures, markets and/or distributes more than 1 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Rhofade
Generic name: oxymetazoline Drug class: topical anti-rosacea agents |
124 reviews | 3.2 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
Discontinued Drugs
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Eskata
Generic name: hydrogen peroxide Drug class: topical anti-infectives |
9 reviews | 1.2 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
